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Particulate drug carriers, including liposomes, are rapidly removed from blood by cells of the reticuloen- 
dothelial system (RES) with resulting adverse ffects on this important host defense system. In order to over- 
come this and other major disadvantages of liposomes, we have altered liposome composition i an effort 
to achieve prolonged circulation half-lives. Gangliosides and sphingomyelin act synergistically to dramati- 
cally diminish the rate and extent of uptake of liposomes by macrophages in vivo. The significantly extended 
circulation times achieved by these modified large unilameUar liposomes overcome an important barrier to 
the targeting of particulate drug carriers to specific tissues in vivo. 
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1. INTRODUCTION 
For many years various types of  particulate drug 
carriers have been investigated with the aim of 
perfecting drug-delivery systems which will localize 
drugs to their desired in vivo target tissue, thus 
minimizing their side effects [1]. Liposomes are in 
some ways ideal drug carriers being biodegradable 
and of minimal toxicity; however, there are impor- 
tant drawbacks to their use in vivo. We show here 
how it is IJossible to overcome otte of  the ma~or 
hurdles to the in vivo use of liposomes as drug 
carriers. 
In spite of a lipid composition which closely 
re~em~>)es ~a~ o~ ce)) membra:~es, )~posomes ate 
recognized as foreign by the cells of the reticuloen- 
dc¢~telial sFsCem (I~ES~. This results itt their ragid 
remova~ ~rom c'trcCtation ~o~iowing intravenous 
administration primarily by Kupffer cells of the 
liver and fixed macrophages of  the spleen. Up ~o 
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85°/O of large egg phosphatidylcholine/cholesterol, 
2: 1 (egg PC : CH) liposomes can be found in liver 
and spleen 0.5 h post-injection [2,3]. The reason 
for the efficient uptake of injected liposomes by 
RES cells is not currently well understood, but is 
though~ to be related to the opson~zafion of 
liposomes by plasma proteins [4]. This rapid 
localization of liposomes in the RES has at least 
two important consequences. Firstly, drug carriers 
which localize rapidly in the RES cannot be 
targeted to non-RES tissues in a specific manner 
which results, therefore, in a severe limitation of 
their therapeutic potential. Secondly, multiple 
liposome injections over a period of several days 
which is an important component of the host 
defense srstem (6l. 
One of "the mos~ notable differences between 
liposomal membranes and cell membranes i the 
presence of  large amo~wts of  surface car- 
bohydrates on the latter, and in particular the 
presence of surface sialic acid residues which im- 
part negative charge to the surface membrane. The 
role of cell surface carbohydrates in cellular 
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recognition phenomena is widely appreciated, 
although poorly understood [7,8]. Enzymatic 
removal of sialic acid from circulating cells results 
in their rapid uptake into Kupffer cells of the liver 
[9-11]. A series of experiments in mice was 
therefore conducted to examine the effect of 
liposomal surface sialic acid, in the form of 
gangliosides, on RES uptake of liposomes in vivo. 
Earlier experiments have shown that inclusion of 
ganglioside in egg PC:CH liposomes greatly 
reduces their susceptibility to lysis and contents 
leakage induced by plasma components [12]. We 
also examined the effect of increasing bilayer 
rigidity, as we have previously found that increas- 
ing rigidity decreases interactions of liposomes 
with high density lipoproteins [13] and increases 
circulation times [2]. 
2. EXPERIMENTAL 
Gangliosides (Supelco, Bellefonte, PA) were 
dissolved in chloroform/methanol (2: l) and ali- 
quots were added to appropriate mixtures of egg 
PC, bovine brain sphingomyelin (SM, Avanti, Bir- 
mingham, AL) and cholesterol (Sigma, St. Louis, 
MO) in chloroform prior to evaporation oforganic 
solvent. Buffer (5 mM Tes, 100mM NaCl, 
0.1 mM EDTA) containing sufficient cpm of 125I- 
tyraminylinulin [14] was added during liposome 
preparation to result in 105-106 cpm/mouse of en- 
trapped label. Large unilamellar liposomes (LUV) 
were prepared according to Szoka and Papahad- 
jopoulos [15] and extruded through 0.4/zm 
Nucleophore filters according to Olsen et al. [16]. 
Liposomes were sized on a Nicomp Instruments 
laser particle sizer. Liposomes extruded through a 
0.4/zm filter averaged 0.17 + 0.05/zm in diameter 
and liposomes extruded through a 0.2/zm filter 
averaged 0.16 _+ 0.05/zm diameters. Sizes were 
very consistent from sample to sample. ICR mice 
(3 per group) were injected in the tail vein with 
0.5 mg phospholipid in 0.2 ml buffer and samples 
of blood and tissues were obtained at the ap- 
propriate times. Some mice were injected with free 
label. Whole organs, carcass or 100/zl blood were 
counted for ~25I in a Beckman 8000 gamma 
counter. Blood volume was taken to be 7% of 
body weight, and tissue counts were corrected for 
counts present in blood. 
3. RESULTS AND DISCUSSION 
In our initial experiments we explored the effect 
of the type of ganglioside and ganglioside concen- 
tration on large unilamellar liposomes (LUV) com- 
posed of egg PC:CH (2:1). LUV have the 
advantage of entrapping large volumes of drug 
solution, but their utility is usually limited due to 
the rapid rate at which they are taken up by the 
RES. The effect of increasing monosialylgan- 
glioside (II3NeuAc-GgOse4Cer, GMI) concentra- 
tions on LUV levels in blood, liver and spleen is 
shown in fig.1. Liver uptake was dependent on 
ganglioside concentration, with peak blood levels 
and minimum liver uptake observed at 5-7 tool%0 
gangliosides. GM1 could increase circulating blood 
levels of liposomes from 3- to 10-fold at optimum 
ganglioside concentrations for egg PC : CH 
liposomes. However, uptake into the RES still re- 
mained high with more liposomes present in liver 
and spleen than were present in blood 2 h post- 
injection. The ratio of %o injected liposomes re- 
maining in blood to that in liver plus spleen is 
termed the blood/RES ratio. No significant levels 
of liposomes were observed in any other tissues or 
in carcass (not shown). 
In our next experiment we substituted high con- 
centrations of sphingomyelin (SM) for egg PC in 
LUV and examined the effect of increasing GM1 
concentration blood, liver and spleen levels. SM 
has a bilayer-rigidifying effect due to its ability to 
form intermolecular hydrogen bonds [13]. The 
result was a dramatic increase in levels of cir- 
culating liposomes and a concomitant decrease in 
uptake into liver and spleen (fig. 1B). Maximum ef- 
fects were observed in the range 7-15 mol%0 GMI. 
However, at 15 mol% GMI the liposomes ex- 
perienced a significant increase in the rate of con- 
tents leakage in blood, and even at 7 mol% GM1 
the liposomes were rather leaky (not shown). RES 
levels of SM:PC (4: 1) LUV (0.17/zm) at optimum 
ganglioside concentrations, were more than 
20-fold lower than those seen for similar sized egg 
PC:CH in the absence of gangliosides, and 
blood/RES ratios at the 2 h sampling time were 
more than 25-fold greater than those for PC:CH, 
2:1 LUV (0.17,um). 
Residence time for intact liposomes in blood 
reflects both lack of RE uptake and liposome 
stability to degradation by plasma proteins. 
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Fig.l. Tissue distribution of liposomes containing entrapped ~zsI-tyraminylinulin, 2 h post-injection, as a function of 
ganglioside concentration. (A) LUV (0.17 #m) of egg PC'CH, 2:1 containing anglioside GM~ (Supelco, Bellefonte, 
PA): liver (A), spleen (=), blood (e). (B) LUV (0.17 am) of SM:PC, 4:1 containing GMI: liver (Zx), spleen (n), blood 
Because the SM:PC:GM~, 4:1:0.35 liposomes 
had lost up to 90°70 of their entrapped contents by 
24 h post-injection, we used the more stable 
liposome composition SM:PC:GMI,  1 : 1:0.14 for 
a subsequent experiment. Less than 20°70 of in- 
jected liposomes, in spite of their large size, were 
localized in liver and spleen 24 h post-injection and 
more than 60070 of contents were still present in 
vix;o (fig.2). This contrasts with the more than 50070 
of  PC: CH, 2 : 1, LUV (0.17/zm) present in liver 
and spleen at the same time point (not shown). Be- 
tween 6 and 24 h post-injection the intact lipo- 
somes moved from circulation into carcass 
(fig.2A). Free label was rapidly eliminated from 
the body (fig.2B). Higher whole body levels of free 
counts 0.5 h post-injection reflect high carcass 
levels which include free counts in urinary bladder, 
the site of elimination of this label [161. 
The increased circulation times of the modified 
liposomes can be directly attributed both to the 
presence of surface sialic acid and to the achieve- 
ment of optimum bilayer stability (table 1). Addi- 
tion Of GMt at 7 mol% to PC:CH LUV (0.17/2m) 
caused an increase in the blood/RES ratio by a fac- 
tor of 13 at 2 h post-injection. However, 7 mo1070 
asialylganglioside (ASGM~, Supelco) increased 
(o). 
blood/RES ratios less than 5-fold (table 1). Inclu- 
sion of 80 mo1070 SM in PC liposomes resulted in 
a 60-fold increase in blood/RES ratio, and addi- 
tion of 7 mo1070 GM1 caused an additional 6-fold 
increase (table 1). Inclusion of 7 mol°70 ASGMt in 
SM :PC liposomes lightly decreased blood/RES 
ratio. These results indicate the importance of 
sialic acid rather than neutral carbohydrate in the 
observed effect. 
The effect of various manipulations of bilayer 
rigidity 2 h post-injection is also reported in table 
1. Addition of cholesterol, which has a bilayer 
tightening effect in fluid liposomes, to egg PC 
liposomes increased the blood/RES ratios by 
13-fold. Liposomes composed of pure DSPC or 
SM, which are below or near their phase transition 
at 37°C, had a low blood/RES ratio, but addition 
of 20 mo1070 egg PC or 33 mo1070 cholesterol to SM 
liposomes, or 7 mo1070 GM1 to DSPC liposomes 
(fluidizing effect) resulted in significantly higher 
blood/RES ratios (table 1) than those seen for 
either liquid-crystalline or gel state liposomes. Ad- 
dition of 7 mo1070 GM~ tO SM liposomes resulted in 
liposomes which were very leaky in vivo (table 1). 
Addition of cholesterol, however, to SM: PC, 4: 1 
liposomes, with or without GM~, decreased the 
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Fig.2. Tissue distribution in mice (n = 3) of liposomes 
containing ~25I-tyraminylinulin of free marker as a 
function of time post-injection. (A) SM:PC:GM~, 
1:1:0.14 (0.2/~m LUV); (B) free ~25I-inulin. Total 
counts in vivo (~), blood (©), liver (zx), spleen (o), 
carcass, including bladder (v). 
b lood /RES ratio primarily due to increased uptake 
to l iposomes into spleen. Cholesterol can interfere 
with the hydrogen-bonding ability of  SM and 
cause a destabilization of  SM bilayers to serum 
components [13]. It would appear that an op- 
t imum bilayer viscosity, occupying an intermediate 
value between liquid-crystalline and gel phase 
lipid, results in optimal circulation times for 
l iposomes. These data clearly demonstrate that 
surface sialic acid and bilayer viscosity have a 
synergistic effect in increasing circulating times of  
l iposomes, however sulfatides which, like 
gangliosides, impart surface hydrophil icity and 
negative charge to the l iposome surface are also 
capable of  increasing b lood/RES ratios, although 
less effectively than GMI (table 1). 
Our results have important implications for the 
use of  liposomes as a slow release drug-delivery 
system within the vasculature, particularly because 
prolonged circulation times have now been 
Table 1 
Effect of ganglioside GMI, cholesterol or combination of the two on 
blood/RES ratios for liposomes of varying compositions, 2 h post-injection 
(mean ± SD, n = 3) 
Composition Size Blood/RES % remaining 
(um) in vivo 
PC 0.17 0.010 ± 0.005 86.0 ± 5.4 
PC:CH,  2: I  0.17 0.13 ± 0.08 78.1 ± 0.04 
PC:GM~, 1:0.07 0.17 0.17 + 0.12 79.4_+ 5.9 
PC:CH:GM1, 2:1:0.14 0.16 1.7 _+ 0.5 75.6 ± 5.7 
PC:CH:ASGM~, 2:1:0.14 0.16 0.62 _+ 0.44 64.8 ± 1.6 
DSPC 0.17 0.015 + 0.002 91.2 ± 2.00 
DSPC:CH, 2:1 0.17 0.007 ± 0.00 101.2 ± 2.4 
DSPC:GMI, 1:0.07 0.17 2.0 ± 0.02 76.7 _+ 3.1 
DSPC:CH:GMI, 2:1:0.14 0.17 3.2 ± 1.0 64.6 ± 3.5 
SM 0.17 0.02 + 0.01 27.1 _+ 3.1 
SM:CH, 2:1 0.17 0.7 ± 0.2 71.9 ± 4.4 
SM:GMh 1:0.07 0.17 5.7 _+ 1.8 12.4 ± 0.7 
SM:CH:GM~, 2:1:0.14 0.17 4.6 ± 0.6 72.1 ± 1.5 
SM:PC, 4:1 0.17 0.6 ± 0.2 69.0 ± 3.3 
SM:PC:CH,  4 : I :3  0.17 0.12 ± 0.06 69.9 ± 2.2 
SM:PC:CH:SO4,4 : l :3 :0 .35  0.17 0.43 ± 0.21 78.4 ± 1.4 
SM:PC:GM~, 4:1:0.35 0.16 3.3 ± 0.3 61.8 _+ 2.9 
SM:PC:CH:GM~, 4:1:3:0.35 0.16 1.5 ± 0.6 88.5 ± 3.0 
SM:PC:ASGMI, 4:1:0.35 0.16 0.9 ± 0.5 80.3 ± 2.5 
GMI and ASGMI concentrations are expressed as the molar ratio of total 
phospholipid. The ratio of % injected counts in blood to % injected counts 
in liver plus spleen is termed blood/RES ratio 
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achieved for large unilamellar liposomes which 
have a large entrapped volume and efficient drug 
capture characteristics. There are also important 
applications for the use of these modified lipo- 
somes in order to target drugs to tissues other than 
spleen, liver and lung by means of tissue-specific 
antibodies covalently coupled to the liposome sur- 
face. In addition, the potential of multiple ad- 
ministrations of liposomes to cause impaired 
functioning of the RES will be considerably re- 
duced through the use of these modified liposomes 
which appear to avoid substantially uptake by the 
RES. 
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